查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835244

髋关节置换植入术市场（依手术方法、固定方法、材料组合、手术类型和最终用户）—2025-2032 年全球预测

Hip Replacement Implant Market by Surgical Approach, Fixation Method, Material Pairing, Procedure Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年髋关节置换植入术市场规模将成长至 127.5 亿美元，复合年增长率为 7.77%。

主要市场统计数据
基准年2024年 70亿美元
预计2025年 75.6亿美元
预测年份：2032年 127.5亿美元
复合年增长率（%） 7.77%

为髋关节置换植入术领域提供策略方向，综合临床驱动因素、技术进步与高阶主管采购现实

髋关节置换置换术仍然是肌肉骨骼医学领域最具影响力的治疗方法之一，这得益于人口结构的变化、慢性病负担的增加以及患者对治疗结果和康復速度不断提升的期望。植入材料和固定技术的进步，加上外科手术的创新，正在为不同类型的患者拓展治疗选择，而医疗服务模式也正在将手术从住院转移到门诊。同时，支付方和医疗机构正在加强对价值的审查，并越来越多地将临床证据与购买决策联繫起来。

临床医生和采购主管需要权衡一系列复杂的因素，包括使用寿命、穿戴式、术中效率和总费用。技术应用并非一成不变，地理和机构差异决定了机器人、导航和微创技术的采用。对法律规范和上市后监测的期望也在不断变化，这使得可靠的临床数据和长期疗效更有价值。这些动态因素正在挑战製造商、医疗系统和经销商采取更整合的策略，将产品开发与付款人参与和医疗保健提供者培训相结合，以确保创新转化为临床和经济效益的可衡量改善。

本执行摘要概述了近期至中期影响竞争定位的关键动态，强调需要在研发、上市和营运方面采取协调行动，以应对不断变化的需求模式，同时保持法规遵从性和临床医生的信心。

临床、技术和供应方面的综合变化正在重新定义髋植入创新如何转化为供应商的采用和商业性价值

在材料和技术的不断进步以及颠覆性数位化能力的推动下，髋植入领域正在加速变革。陶瓷复合材料、高交联聚乙烯和表面涂层的创新推动了材料科学的进步，这不仅推动了现代轴承性能的提升，也改变了外科医生的偏好和重新置换方案。手术技术也在不断发展，随着医疗服务提供者追求更快的康復时间和更短的住院时间，微创手术和保留组织的入路变得越来越普遍。这种临床转变是由诊断成像、增强型术中引导和机器人技术的采用所推动的，这些技术正在改善植入的定位和可重复性。

同时，医疗保健服务正在适应财务和物流压力。门诊手术中心的扩张正在改变器械选择标准，强调可预测的手术时间和易于盘点的植入。供应链弹性正变得越来越重要，促使原始设备製造商 (OEM) 实现采购多元化，并策略性地储备库存，以应对市场中断。报销模式正朝着事件为基础的支付方向发展，奖励器械和照护途径，从而减少再入院和重复住院。因此，商业策略正在转向强调疗效证据、外科医生培训计划和上市后监测。

要在这一领域取得成功，需要在临床证据生成、外科医生数位化以及将产品价值与不断发展的医疗服务模式相结合的营运机制方面进行全面投资。

2025 年美国关税对髋关节植入技术采购、定价策略和临床可近性的营运和策略影响

2025年美国新关税的实施，标誌着全球髋植入供应动态和筹资策略的重要曲折点。关税将增加进口零件和成品的到岸成本，迫使製造商和经销商重新评估其采购足迹和合约结构。为此，许多供应商正在加速近岸外包，将关键製造业务转移到免关税管辖区，或重新配置零件采购，以最大限度地降低关税的影响。除了这些营运方面的应对措施外，供应商还正在与医疗系统重新谈判合同，以寻求更高的价格透明度和风险分担安排，从而降低采购成本的增加。

医院和门诊中心面临着在持续护理和成本控制之间进行权衡的问题。一些机构正在寻求批量折扣、延长保固期和外包模式来管理营运资金，同时维护现有的供应商关係。另一些机构则在实现供应商多元化，例如选择国内製造商和替代材料组合，以便在不影响临床疗效的情况下提供优惠价格。重要的是，海关环境非常重视供应链的透明度和分类的准确性，因为关税代码和产品分类对海关责任有重大影响。

从策略角度来看，拥有灵活生产布局、垂直整合能力和完善监管文件的供应商，能够更好地吸收或抵销关税带来的成本压力。具有前瞻性的公司将投资于长期供应商多元化，提升海关和贸易合规能力，并与付款方和供应商合作，建立基于价值的采购安排，以共用短期成本衝击的负面影响，同时确保获得临床所需的解决方案。

以细分市场为中心的情报，揭示手术方法、固定、材料、手术类型和最终用户的差异化临床需求、预期设备性能和采购驱动因素

对市场进行详细的細項分析，可以揭示临床需求、营运可行性和机会的交会点。手术入路分为微创入路和传统入路，微创入路进一步分为前路入路和后外侧入路，传统入路又进一步分为前路入路和后路入路。每种入路都有其独特的器械需求、植入几何形状和手术全期方案，这些都会影响外科医师的偏好和医院的器械库存决策。例如，微创前路入路通常优先考虑能够保留肌肉并缩短復健期的植入和器械，而传统后路入路则可能更倾向于选择具有成熟长期疗效数据且与传统器械相容性更高的植入。

骨水泥、非骨水泥和混合固定方法之间的差异为不同的患者群体创造了差异化的价值提案。非骨水泥系统强调骨整合和模组化，并通常与先进的表面处理相结合以促进新骨形成。材料组合分为陶瓷-陶瓷、陶瓷-聚乙烯、金属-金属和金属-聚乙烯。陶瓷-陶瓷进一步分为氧化铝-氧化铝和氧化锆-氧化锆两种类型，而陶瓷-聚乙烯则进一步分为氧化铝-聚乙烯和氧化锆-聚乙烯。金属-金属和金属-聚乙烯组合同样细分为钴铬或钛组合以及匹配或聚乙烯组合。这些材质组合会影响磨损行为、杂讯风险、影像伪影轮廓和重新置换策略，进而影响临床医师的选择和采购谈判。

手术类型分为初次手术和重新置换手术，初次手术又分为双侧手术和单侧手术，重新置换手术又分为髀臼修復手术、双侧修復手术和股骨重新置换手术。不同手术类型的技术复杂性、库存要求和成本影响差异很大，重新置换手术通常需要模组化扩展和更专业的植入。门诊手术中心和医院的最终用户细分不同，因此购买标准也不同。门诊手术中心优先考虑支援快速吞吐和可预测结果的植入，而医院则重视更广泛的病例组合灵活性和纵向登记资料。这种综合细分为产品开发、临床教育和报销参与提供了有针对性的路径，与每个细分市场的临床和营运重点一致。

比较影响美洲、欧洲、中东和非洲地区以及亚太地区监管策略、采购重点和实施路径的区域动态

区域动态显着影响采用曲线、监管途径和商业性重点，为市场进入和扩张制定了清晰的策略。在美洲，成熟的报销生态系统和门诊手术中心的高渗透率正在加速人们对可减少住院时间并支持快速康復通讯协定的植入的兴趣。该地区还强调稳健的纵向结果和註册，这增强了临床医生和付款人对成熟技术的信心。美洲的监管参与和付款人谈判通常优先考虑真实世界证据和基于价值的合同，以使产品采用与财务课责保持一致。

欧洲、中东和非洲的管理体制和报销框架各不相同，因此需要製定针对特定地区的策略。一些欧洲市场实行集中采购机制和比较有效性评估，倾向具有强有力临床证据且经济高效的解决方案。中东市场越来越容易接受捆绑培训和服务的高端技术，而许多非洲市场则优先考虑价格实惠和供应可靠性。因此，供应商必须调整其产品以适应当地采购标准，并投资于有针对性的临床和商业性支持，以克服市场碎片化。

亚太地区的特点是销售量快速成长、手术能力不断提升，且各国医疗体系的成熟度参差不齐。一些国家在采用本地製造能力和技术创新方面处于领先地位，而另一些国家仍在建立手术能力和註册基础设施。在临床医生专业知识不断提升和私人手术设施不断扩张的推动下，该地区在采购成本敏感型产品的同时，也迅速采用了先进材料和数位化手术器械。这些地区差异凸显了差异化市场策略的必要性，这些策略需要考虑监管的复杂性、本地製造能力，以及在高端产品和高性价比产品之间取得平衡。

竞争动态和供应商策略将产品创新、临床证据产生和服务主导的差异化相结合，以在价值驱动的环境中获胜

供应商生态系统不断发展，现有企业不断拓宽产品供应，新兴企业透过材料创新、模组化架构和服务主导提案开拓利基市场。竞争差异化越来越依赖临床证据、外科医生培训和支持，以及涵盖植入物本身、仪器仪表、数位化规划工具和售后服务等全方位植入的结合。该行业普遍采取的策略行动包括：垂直整合以确保关键零件供应；与机器人和导航开发商建立选择性合作伙伴关係；以及投资临床註册专案以强化安全性和有效性声明。

商业模式也在多样化。一些供应商强调捆绑解决方案和基于疗程的定价，直接与医疗服务提供者和付款人合作，根据疗效调整奖励。另一些供应商则优先与外科医生密切合作，透过教育中心、尸体实验室和监考计画来推广手术的采用。配送和物流能力也是差异化因素，尤其是在供应链可靠性影响采购决策的地区。能够提供可预测的服务水准、灵活的合约安排和快速回应的临床支援的组织在采购谈判中将获得竞争优势。

成功的市场参与企业将取决于能否在短期商业性利益与长期投资（在证据生成和临床医生伙伴关係）之间取得平衡。将产品性能与卓越营运和可证明的疗效相结合的公司将占据有利地位，能够影响处方并确保持续的优先使用。

製造商、医疗保健提供者和经销商应采取切实可行的优先行动，以增强韧性、加速采用并在临床和政策转变中获取价值

产业领导者应采取多维度策略，将产品创新与营运韧性和付款人参与度相结合。首先，实现製造和供应商关係多元化，以降低贸易政策波动带来的风险，并确保向大批量生产中心稳定供应。建立区域生产能力或多源关键部件，以保持连续性并确保成本可预测性。其次，优先投资微创平台和模组化植入系统，以满足对更快恢復和多样化重新置换方案日益增长的需求。全面的外科医生培训、术中规划工具和结果追踪可以补充产品发布，缩短引进週期，并建立真实世界证据。

第三，我们将积极与付款方合作，制定基于价值的方案，以奖励疗效和成本控制。我们将建立试点项目，展示住院时间、再入院率和再手术率的降低，并利用这些成果来协商优先产品路径。第四，我们将优化门诊手术中心的商业模式，将其与支援提高吞吐量、简化器械和即时供应的捆绑服务相结合。第五，我们将加强上市后监测和数据分析能力，以便及早发现绩效趋势，并支持监管提交和竞标流程。最后，我们将透过投资海关专业知识、提高关税分类准确性和灵活的物流，为法规和贸易政策的变化製定情境规划，以在不断变化的外部环境中保持竞争力。

实施这些行动需要研发、供应链、临床和商业团队的跨学科协调，以确保对产品和流程的投资能带来临床结果和财务绩效的可衡量的改善。

调查方法的透明度：描述支撑我们研究结果的主要和次要证据收集、三角测量方法和品管

本分析基于严格的混合方法研究设计，将主要相关人员的参与与全面的二手证据整合相结合。主要资讯包括与骨科医生、医院采购负责人、门诊手术中心管理人员、监管专家和高级商务主管进行结构化访谈，以掌握关于临床偏好、采购动态和营运挑战的第一手观点。这些定性见解辅以同行评审的临床文献、设备註册、监管提交文件和程序指南的审查，以检验技术性能声明和长期安全信号。

二次研究涵盖公共文件、贸易数据和临床实践建议，并模拟了监管变化、关税效应和采用模式之间的相互作用。采用数据三角测量法来协调差异，并确保结论是基于多个独立资讯来源。品质保证程序包括访谈记录的交叉检验、证据选择的方法学审核以及临床和市场进入专家的内部同行评审。我们承认存在证据缺口的局限性，尤其是对于缺乏长期结果数据的新材料或新型微创技术的组合。

总体而言，该调查方法在临床洞察的深度和商业性知识的广度之间取得平衡，透明地记录假设和证据来源，同时得出可靠且可行的结论。

整合高阶主管必须协调的策略重点和风险考虑，以将创新转化为可衡量的临床和商业性成果

人口结构需求、材料和手术创新以及医疗服务模式的转变，使髋植入产业正处于曲折点，战略远见将获得回报。临床进展和数位化应用为改善患者治疗效果和营运效率创造了机会，但也提高了证据产生、供应链敏捷性以及与付款人的商业性协调的标准。关税相关的成本压力和区域监管的复杂性进一步凸显了对灵活应变的生产布局和积极主动的贸易合规性的必要性。

整合临床、商业和营运策略的相关人员最有可能获得持续价值。这需要优先考虑可靠的临床证据，投资外科医生培训和数位化规划工具，实现供应链多元化，并让付款方参与基于价值的安排。应用这些原则不仅有助于製造商保护净利率，还能透过可证明的疗效和灵活的商业模式扩大可及性，并使医疗服务提供者能够优化护理路径，从而改善康復并提高成本效益。

总的来说，该产业的近期发展轨迹将取决于组织将创新转化为检验的临床效益和营运可靠性的速度，而跨职能协作执行是成功的关键能力。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 实施人工智慧驱动的术前计画和预测模型，以优化髋置换术的结果
  • 针对特定患者的 3D 列印髋植入的需求日益增长，以改善其解剖贴合度和癒合效果
  • 结合机器人辅助微创技术的精准髋关节置换手术
  • 利用先进的多模态疼痛管理扩大门诊髋关节置换手术
  • 促进骨整合和降低感染风险的生物活性植入涂层的开发正在兴起
  • 越来越多地采用模组化双活动植入设计，以最大限度地减少脱位并提高稳定性
  • 瓷质对瓷质接合面和交联聚乙烯轴承表面的进步可延长植入的寿命
  • 越来越多地使用远端医疗平台进行术后监测和个人化物理治疗依从性
  • 透过植入製造商和研究机构之间的策略合作，实现先进植入材料的创新

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8.髋关节置换植入术市场（依手术方法）

  • 微创
    • 前部最小值
    • 后外侧最小值
  • 传统的
    • 前入路
    • 后入路

9.髋关节置换植入术市场（依固定方法）

  • 水泥
  • 非骨水泥
  • 杂交种

第十章髋关节置换植入术市场（依材料组合）

  • 陶瓷与陶瓷
    • 氧化铝与氧化铝
    • 锆石 vs 锆石
  • 聚乙烯与陶瓷
    • 聚乙烯与氧化铝
    • 聚乙烯与氧化锆
  • 金属对金属
    • 钴铬合金与钴铬合金
    • 钛与钛
  • 聚乙烯与金属
    • 聚乙烯与钴铬
    • 聚乙烯与钛

第 11 章髋关节置换植入术市场（依手术类型）

  • 基本的
    • 双方
    • 一边
  • 重新置换
    • 髀臼翻修手术
    • 重新置换手术
    • 股骨重新置换手术

第 12 章髋关节置换植入术市场（依最终使用者划分）

  • 门诊手术中心
  • 医院

13.髋关节置换植入术市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章髋关节置换植入术市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15.髋关节置换植入术市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • DePuy Synthes, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • Smith & Nephew plc
    • Exactech, Inc.
    • DJO Global, Inc.
    • B. Braun Melsungen AG
    • MicroPort Scientific Corporation
    • Medacta International SA
    • Corin Group PLC
Product Code: MRR-437E9896A56D

The Hip Replacement Implant Market is projected to grow by USD 12.75 billion at a CAGR of 7.77% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.00 billion
Estimated Year [2025] USD 7.56 billion
Forecast Year [2032] USD 12.75 billion
CAGR (%) 7.77%

A strategic orientation to the hip replacement implant sector that synthesizes clinical drivers, technological advances, and procurement realities for executives

Hip arthroplasty continues to be one of the most impactful interventions in musculoskeletal care, driven by demographic shifts, rising chronic disease burden, and evolving expectations for patient outcomes and recovery speed. Advances in implant materials and fixation techniques are converging with surgical innovation to expand treatment options for heterogeneous patient profiles, while healthcare delivery models are migrating procedures from inpatient wards to ambulatory settings. At the same time, payers and providers are imposing greater scrutiny on value, leading to a tighter coupling between clinical evidence and purchasing decisions.

Clinicians and procurement leaders are navigating a complex matrix of trade-offs that include longevity, wear performance, intraoperative efficiency, and total episode cost. Technology adoption is not monolithic; geographical and institutional differences shape uptake of robotics, navigation, and minimally invasive techniques. Regulatory frameworks and post-market surveillance expectations are also rising, creating a premium for robust clinical data and longitudinal outcomes. These forces collectively demand that manufacturers, health systems, and distributors adopt more integrated strategies that connect product development with payer engagement and provider training, ensuring that innovations translate into measurable improvements in clinical and economic outcomes.

This executive summary frames the critical dynamics that will influence competitive positioning over the near to medium term. It emphasizes the need for coordinated action across R&D, market access, and operations to respond to shifting demand patterns while sustaining regulatory compliance and clinician trust.

Compounding clinical, technological, and supply-side shifts that are redefining how hip implant innovation translates into provider adoption and commercial value

The hip implant landscape is undergoing a period of accelerated transformation as incremental improvements in materials and technique compound with disruptive digital capabilities. Material science progress-driven by innovations in ceramic composites, highly crosslinked polyethylene, and surface coatings-has extended the performance envelope of modern bearings while simultaneously altering surgeon preferences and revision profiles. Surgical technique is also evolving; minimally invasive approaches and tissue-sparing access routes are becoming more prevalent as providers seek faster recovery times and reduced length of stay. These clinical shifts have been catalyzed by enhanced imaging, intraoperative guidance, and adoption of robotics, which collectively improve implant positioning and reproducibility.

Concurrently, care delivery is adjusting to financial and logistical pressures. The expansion of ambulatory surgical centers has changed the calculus for device selection, with a premium on implants that enable predictable operative times and straightforward inventory management. Supply chain resilience has come into sharper focus, prompting OEMs to diversify sourcing and hold strategic inventories to guard against disruptions. Reimbursement models are increasingly oriented toward episode-based payments, incentivizing devices and care pathways that reduce readmissions and revisions. As a result, commercial strategies are adapting to emphasize outcome evidence, surgeon training programs, and post-market surveillance.

Taken together, these transformative shifts reinforce a cross-functional imperative: success in this sector requires integrated investments in clinical evidence generation, digital enablement for surgeons, and operational mechanisms that align product value with evolving care delivery models.

Operational and strategic implications of the 2025 United States tariff measures on sourcing, pricing strategies, and clinical access to hip implant technologies

The imposition of new tariffs by the United States in 2025 has introduced a significant inflection point for global hip implant supply dynamics and procurement strategies. Tariff measures increase landed costs for imported components and finished devices, prompting manufacturers and distributors to reassess sourcing footprints and contract structures. In response, many suppliers accelerate nearshoring initiatives, migrate critical manufacturing steps to tariff-safe jurisdictions, or reconfigure component sourcing to minimize customs exposure. These operational responses are complemented by contract renegotiations with health systems that seek greater price transparency and shared risk arrangements to mitigate increased procurement costs.

Hospitals and ambulatory centers confront trade-offs between continuity of care and cost containment. Some institutions preserve existing supplier relationships but push for volume discounts, extended warranties, or consignment models to manage working capital. Others diversify their supplier base to include domestic manufacturers or alternative material pairings that yield favorable pricing without compromising clinical outcomes. Importantly, the tariff environment has placed a premium on supply-chain visibility and classification accuracy, as tariff codes and product categorizations materially affect duty burdens.

From a strategic perspective, suppliers with flexible manufacturing footprints, vertically integrated capabilities, and established regulatory dossiers are better positioned to absorb or offset tariff-driven cost pressures. Forward-looking organizations invest in long-term supplier diversification, invest in customs and trade compliance capabilities, and collaborate with payers and providers to structure value-based purchasing arrangements that share the downside of short-term cost shocks while preserving access to clinically preferred solutions.

Segment-centric intelligence revealing differentiated clinical needs, device performance expectations, and procurement drivers across surgical, fixation, material, procedure, and end-user dimensions

Analyzing the market through detailed segmentation illuminates where clinical need, operational feasibility, and commercial opportunity intersect. Surgical approach divides into minimally invasive and traditional pathways, with the minimally invasive category further distinguishing anterior minimal and posterolateral minimal techniques, and the traditional category distinguishing anterior and posterior approaches. Each pathway introduces unique instrumentation needs, implant geometries, and perioperative protocols that influence surgeon preference and hospital inventory decisions. Minimally invasive anterior techniques, for example, often prioritize implants and instruments that facilitate muscle-sparing access and quicker rehabilitation, whereas traditional posterior approaches may favor implants with established long-term outcome data and broader compatibility with legacy instrumentation.

Fixation method segmentation-cemented, cementless, and hybrid-creates differentiated value propositions for distinct patient cohorts. Cementless systems emphasize osseointegration and modularity, often paired with advanced surface treatments to promote bone in-growth, whereas cemented options remain relevant for specific anatomical or bone-quality considerations. Material pairing segmentation spans ceramic on ceramic, ceramic on polyethylene, metal on metal, and metal on polyethylene configurations. Ceramic on ceramic further divides into alumina on alumina and zirconia on zirconia variants, while ceramic on polyethylene differentiates alumina on polyethylene and zirconia on polyethylene. Metal on metal and metal on polyethylene combinations are similarly subdivided by cobalt chrome or titanium pairings against matching or polyethylene counterparts. These material permutations affect wear behavior, squeaking risk, imaging artifact profiles, and revision strategies, influencing both clinician selection and procurement negotiations.

Procedure type segmentation separates primary from revision procedures, with the primary category subdivided into bilateral and unilateral cases and the revision category differentiated into acetabular, dual, and femoral revisions. The technical complexity, inventory requirements, and cost implications vary substantially across these procedure types, with revision cases typically necessitating expanded modularity and more specialized implants. End-user segmentation between ambulatory surgical centers and hospitals drives divergent purchasing criteria; ambulatory settings prioritize implants that support rapid throughput and predictable outcomes, while hospitals weigh broader case-mix flexibility and long-term registry data more heavily. Integrating these segmentation lenses reveals targeted pathways for product development, clinical education, and reimbursement engagement that align with each segment's distinct clinical and operational priorities.

Comparative regional dynamics that influence regulatory strategy, procurement priorities, and adoption pathways across the Americas, EMEA, and Asia-Pacific

Regional dynamics shape adoption curves, regulatory pathways, and commercial priorities in meaningful ways, creating distinct playbooks for market entry and expansion. In the Americas, a mature reimbursement ecosystem and a high penetration of ambulatory surgical centers accelerate interest in implants that reduce length of stay and support rapid recovery protocols. This region also places a strong emphasis on robust longitudinal outcomes and registries, which reinforce clinician and payer confidence in proven technologies. Regulatory engagement and payer negotiations in the Americas often prioritize real-world evidence and value-based contracting to align product adoption with fiscal accountability.

Across Europe, the Middle East & Africa, heterogeneous regulatory regimes and varying reimbursement frameworks necessitate region-specific strategies. Several European markets maintain centralized procurement mechanisms and comparative effectiveness evaluations that favor cost-effective solutions with strong clinical evidence. Middle Eastern markets are increasingly receptive to premium technologies when bundled with training and service commitments, while many African markets prioritize affordability and supply reliability. Vendors must therefore calibrate offerings to local procurement norms and invest in targeted clinical and commercial support to overcome market fragmentation.

The Asia-Pacific region is characterized by rapid volume growth, expanding surgical capacity, and divergent maturity across national health systems. Certain countries lead in local manufacturing capabilities and innovation adoption, while others are still building procedural capacity and registry infrastructure. Cost-sensitive procurement coexists with pockets of rapid adoption for advanced materials and digital surgical tools, driven by rising clinician expertise and expanding private-sector surgical facilities. These regional contrasts underscore the need for differentiated go-to-market strategies that account for regulatory complexity, local manufacturing potential, and the balance between premium and cost-effective product tiers.

Competitive dynamics and supplier playbooks that combine product innovation, clinical evidence generation, and service-led differentiation to win in a value-focused environment

The supplier ecosystem continues to evolve, with incumbents refining product breadth and emerging players carving niche positions through material innovation, modular architectures, or service-led propositions. Competitive differentiation increasingly hinges on a combination of clinical evidence, surgeon training and support, and integrated offerings that extend beyond the implant itself to include instrumentation, digital planning tools, and aftermarket services. Strategic behaviors observed across the sector include vertical integration to secure critical component supply, selective partnerships with robotics and navigation developers, and investment in clinical registry programs to reinforce safety and effectiveness claims.

Commercial models are also diversifying. Some suppliers emphasize bundled solutions and episode-based pricing, collaborating directly with providers and payers to align incentives around outcomes. Others prioritize high-touch surgeon engagement through education centers, cadaver labs, and proctoring programs to accelerate technique adoption. Distribution and logistics capabilities are a differentiator as well, particularly in regions where supply-chain reliability influences purchasing decisions. Organizations that offer predictable service levels, flexible consignment arrangements, and responsive clinical support gain a competitive edge in procurement discussions.

Success for market participants depends on balancing near-term commercial wins with long-term investments in evidence generation and clinician partnerships. Firms that combine product performance with operational excellence and demonstrable outcomes are better placed to influence formularies and secure sustained preferential use.

Practical and prioritized actions for manufacturers, providers, and distributors to strengthen resilience, accelerate adoption, and capture value amid clinical and policy shifts

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with operational resilience and payer engagement. First, diversify manufacturing and supplier relationships to reduce exposure to trade-policy volatility and ensure uninterrupted supply to high-volume centers. Establishing regional production capabilities or multi-sourcing for critical components will preserve continuity while delivering cost predictability. Second, prioritize investments in minimally invasive platforms and modular implant systems that address growing demand for faster recovery and versatile revision options. Complement product launches with comprehensive surgeon training, intraoperative planning tools, and outcomes tracking to shorten adoption cycles and build real-world evidence.

Third, engage payers proactively to develop value-based arrangements that reward outcomes and cost containment. Structure pilot programs that demonstrate reductions in length of stay, readmission rates, and revision incidence, and leverage these results to negotiate preferred-product pathways. Fourth, optimize commercial models for ambulatory surgical centers by tailoring bundles that support higher throughput, simplified instrumentation, and just-in-time supply. Fifth, enhance post-market surveillance and data analytics capabilities to detect performance trends early and to support regulatory submissions and tender processes. Finally, scenario-plan for regulatory and trade-policy changes by investing in customs expertise, tariff classification accuracy, and flexible logistics to maintain competitiveness under shifting external conditions.

Implementing these actions requires cross-functional coordination across R&D, supply chain, clinical affairs, and commercial teams, ensuring that investments in product and process translate into measurable improvements in clinical outcomes and financial performance.

Methodological transparency describing primary and secondary evidence collection, triangulation techniques, and quality controls that underpin the executive findings

The analysis draws on a rigorous mixed-methods research design combining primary stakeholder engagement with comprehensive secondary evidence synthesis. Primary inputs include structured interviews with orthopedic surgeons, hospital procurement leaders, ambulatory surgical center administrators, regulatory specialists, and senior commercial executives to capture firsthand perspectives on clinical preferences, purchasing dynamics, and operational challenges. These qualitative insights are complemented by a review of peer-reviewed clinical literature, device registries, regulatory filings, and procedural guidelines to validate technical performance claims and long-term safety signals.

Secondary research encompassed public policy documents, trade data, and clinical practice recommendations to model the interaction between regulatory changes, tariff effects, and adoption patterns. Data triangulation was applied to reconcile divergent viewpoints and to ensure that conclusions are grounded in multiple independent sources. Quality assurance procedures included cross-validation of interview transcripts, methodological audits of evidence selection, and internal peer review by clinical and market-access experts. Limitations were acknowledged where evidence gaps exist, particularly in newer material pairings and emerging minimally invasive techniques that lack long-duration outcome data.

Overall, the methodology balanced depth of clinical insight with breadth of commercial intelligence, enabling robust, actionable conclusions while transparently documenting assumptions and evidence sources.

Synthesis of strategic priorities and risk considerations that executives must align to convert innovation into measurable clinical and commercial outcomes

The convergence of demographic demand, materials and surgical innovation, and shifting care-delivery models positions the hip implant sector at an inflection point that rewards strategic foresight. Clinical advances and digital enablement create opportunities to improve patient outcomes and operational efficiency, but they also raise the bar for evidence generation, supply-chain agility, and commercial alignment with payers. Tariff-related cost pressures and regional regulatory complexity further emphasize the need for adaptable manufacturing footprints and proactive trade compliance.

Stakeholders that integrate clinical, commercial, and operational strategies will be best positioned to capture sustained value. This requires prioritizing robust clinical evidence, investing in surgeon training and digital planning tools, diversifying supply chains, and engaging payers in value-based arrangements. By applying these principles, manufacturers can not only protect margins but also expand access through demonstrable outcomes and flexible commercial models, while providers can optimize care pathways that deliver improved recovery and cost-effectiveness.

Taken together, the sector's near-term trajectory will be determined by the speed at which organizations translate innovation into validated clinical benefit and operational reliability, making coordinated cross-functional execution the defining capability for success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven preoperative planning and predictive modeling to optimize hip replacement outcomes
  • 5.2. Growing demand for patient-specific 3D-printed hip implants to enhance anatomical fit and recovery
  • 5.3. Integration of robotic-assisted minimally invasive techniques for precise hip replacement procedures
  • 5.4. Expansion of outpatient hip replacement surgeries supported by advanced multimodal pain management
  • 5.5. Surge in development of bioactive implant coatings to accelerate osseointegration and reduce infection risk
  • 5.6. Rising adoption of modular dual mobility hip implant designs to minimize dislocation and improve stability
  • 5.7. Evolution of ceramic-on-ceramic and crosslinked polyethylene bearing surfaces to extend implant longevity
  • 5.8. Increasing use of telemedicine platforms for postoperative monitoring and personalized physical therapy adherence
  • 5.9. Strategic collaborations between implant manufacturers and research institutions to innovate advanced implant materials

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hip Replacement Implant Market, by Surgical Approach

  • 8.1. Minimally Invasive
    • 8.1.1. Anterior Minimal
    • 8.1.2. Posterolateral Minimal
  • 8.2. Traditional
    • 8.2.1. Anterior Approach
    • 8.2.2. Posterior Approach

9. Hip Replacement Implant Market, by Fixation Method

  • 9.1. Cemented
  • 9.2. Cementless
  • 9.3. Hybrid

10. Hip Replacement Implant Market, by Material Pairing

  • 10.1. Ceramic on Ceramic
    • 10.1.1. Alumina on Alumina
    • 10.1.2. Zirconia on Zirconia
  • 10.2. Ceramic on Polyethylene
    • 10.2.1. Alumina on Polyethylene
    • 10.2.2. Zirconia on Polyethylene
  • 10.3. Metal on Metal
    • 10.3.1. Cobalt Chrome on Cobalt Chrome
    • 10.3.2. Titanium on Titanium
  • 10.4. Metal on Polyethylene
    • 10.4.1. Cobalt Chrome on Polyethylene
    • 10.4.2. Titanium on Polyethylene

11. Hip Replacement Implant Market, by Procedure Type

  • 11.1. Primary
    • 11.1.1. Bilateral
    • 11.1.2. Unilateral
  • 11.2. Revision
    • 11.2.1. Acetabular Revision
    • 11.2.2. Dual Revision
    • 11.2.3. Femoral Revision

12. Hip Replacement Implant Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Hip Replacement Implant Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hip Replacement Implant Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hip Replacement Implant Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. DePuy Synthes, Inc.
    • 16.3.2. Zimmer Biomet Holdings, Inc.
    • 16.3.3. Stryker Corporation
    • 16.3.4. Smith & Nephew plc
    • 16.3.5. Exactech, Inc.
    • 16.3.6. DJO Global, Inc.
    • 16.3.7. B. Braun Melsungen AG
    • 16.3.8. MicroPort Scientific Corporation
    • 16.3.9. Medacta International SA
    • 16.3.10. Corin Group PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. HIP REPLACEMENT IMPLANT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. HIP REPLACEMENT IMPLANT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HIP REPLACEMENT IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEM